Navigation Links
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
Date:1/8/2008

Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended September 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Exe
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... June 29, 2015 The Parenteral Drug Association ... Jersey Board of Professional Engineers and Land ... courses to professional engineers for continuing professional competency (CPC) ... the value and quality of PDA,s professional education offerings," ... courses and hands-on professional training at the Training and ...
(Date:6/29/2015)... June 29, 2015  Pressure BioSciences, Inc. (OTCQB: ... the development and sale of broadly enabling, pressure ... worldwide life sciences industry, today announced that Tiannan ... Systems Biology, ETH Zurich, presented data on an ... of prostate cancer tissue biopsy samples at the ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Association rapid access journal report:Study highlights:-- Implantable ... of death by 30 percent in patients ... applied to patients 75 years and older ... have focused on younger, healthier patients.DALLAS, Jan. ...
... Corporation (Nasdaq: MNKD ) today announced ... its commercial inhaler to the version of the device ... MannKind,s ultra rapid acting insulin that recently completed Phase ... Clinical and Commercial Scale Inhalers Study 138 compared the ...
Cached Medicine Technology:Implantable Defibrillators Lower Risk of Death in Older Heart Patients 2Implantable Defibrillators Lower Risk of Death in Older Heart Patients 3MannKind Reports Successful Completion of Device Bioequivalence Trial 2MannKind Reports Successful Completion of Device Bioequivalence Trial 3
(Date:6/29/2015)... , ... June 29, 2015 , ... With Urgent Care ... a partnership with the American Board of Urgent Care Medicine and the Medical Society ... 1 Credit™ to Urgent Care physicians and health care professionals. , According to Matthew ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... 29, 2015 , ... The Food Safety and Technology Research ... Kong Polytechnic University (PolyU) has developed a new method for rapid authentication of ... a long-term issue in food safety, and becomes particularly important with the emergence ...
(Date:6/29/2015)... ... June 29, 2015 , ... DISC, a ... is a popular focus for corporate training seminars. As many as seventy percent ... training, foster teamwork, and increase productivity. , With the demand for in-house ...
(Date:6/29/2015)... ... June 29, 2015 , ... Wheel:Life, ... Travel Guide for Wheelchair Users as a new e-book on Amazon.com. Wheel:Life publications ... , These accessible travel suggestions were crowdsourced by the Get Out & Enjoy ...
Breaking Medicine News(10 mins):Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3
... S.C., June 26 Southern Home Medical,Equipment, Inc. ... Medical Staffing of Greenville, S.C. has completed its ... shifts., Greg Tucker, President and CEO of ... doing extremely well. The Greenville team has far,exceeded ...
... June 26, 2008 -- Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), announced ... candidate in its Beta-catenin Pathway Inhibitor program. This novel compound ... cancer cell death. The Company plans to begin ... is one of the most commonly activated cancer pathways and ...
... La., June 26 Lee Pryor, CEO of ... courseware and,learning management solutions, announced Portico,s partnership with ... such as FOX,Sports, FOX Cable Networks, FOX Reality, ... a global initiative across all News Corporation businesses,FNG ...
... Demo Showcases That Yesterday,s FCC Mandate is Quick ... GoAmerica, Inc.,(Nasdaq: GOAM ), a provider of ... deaf, hard-of-hearing, and,speech-disabled persons, and AT&T today announced ... live point-to-point video call through a,10-digit numbering system ...
... The International Association for Dental Research (IADR) is ... Senior Lecturer in Periodontology at the School of Dental ... award will be presented at the IADR 86th General ... 2008., Dr. Preshaw holds a B.D.S. from Newcastle University, ...
... Dental Research (IADR) has selected Dr. Stuart Fischman, ... of Dental Medicine, at the State University of ... Pharmacology/Therapeutics/Toxicology Research Award. The award will be presented ... Toronto, ON, Canada on July 2, 2008., Dr. ...
Cached Medicine News:Health News:Encore Medical Staffing of Greenville Signs Seventh Staffing Agreement 2Health News:Avalon Pharmaceuticals names lead development candidate in beta-catenin inhibitor program 2Health News:FOX Networks Group in Partnership with Portico Learning Solutions Launches Online Employee Health and Safety Orientation Course for Over 3,300 Employees 2Health News:GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers 2Health News:GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers 3Health News:GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers 4Health News:GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers 5Health News:Fischman receives Pharmacology/Therapeutics/Toxicology Research Award 2
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: